Magnesium is named as an intervention in 5 current clinical trials in our Egypt, Canada and Israel registers. 3 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is Zagazig University (2). The most-studied condition is Steroid Metabolism Disorder.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Low Sodium Oxybate in Patients With Idiopathic Hypersomnia
NCT05837091 · ClinicalTrials.gov ↗ · Idiopathic Hypersomnia
|
Phase 4 | Recruiting | Mayo Clinic | Israel |
|
Magnesium Injection Ensures Steroid Avoidance During Vaccine, Viremia or Immunocompromise
NCT05862454 · ClinicalTrials.gov ↗ · Steroid Metabolism Disorder
|
Observational | Recruiting | Salem Anaesthesia Pain Clinic | Canada |
|
Efficacy of Dexmedetomidine VS Magnesium Sulphate With Bupivacaine in Erector Spinae Block for Thoracotomy Pain
NCT05851768 · ClinicalTrials.gov ↗ · Analgesia
|
Not applicable | Recruiting | National Cancer Institute, Egypt | Egypt |
|
Oral Intake of Mg in Controlled Asthmatic Patients
NCT06721247 · ClinicalTrials.gov ↗ · Bronchial Asthma
|
Phase 2/3 | Active, closed | Zagazig University | Egypt |
|
Total Intravenous Anesthesia in Patients Undergoing Craniotomy
NCT07105618 · ClinicalTrials.gov ↗ · Anesthesia
|
Not applicable | Active, closed | Zagazig University | Egypt |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| Zagazig University | 2 |
| Salem Anaesthesia Pain Clinic | 1 |
| Mayo Clinic | 1 |
| National Cancer Institute, Egypt | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Egypt | 3 | 1 |
| Clinical trials in Canada | 1 | 1 |
| Clinical trials in Israel | 1 | 1 |
A trial with sites in more than one country appears in each of those registers.
5 current trials in our Egypt, Canada and Israel registers name Magnesium as a drug or biological intervention, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of the 5 trials are recruiting: 1 with sites in Egypt, 1 with sites in Canada and 1 with sites in Israel. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Zagazig University (2), Salem Anaesthesia Pain Clinic (1), Mayo Clinic (1) and National Cancer Institute, Egypt (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Magnesium works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Magnesium works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Magnesium (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 26 Sep 2026.